Loading clinical trials...
Loading clinical trials...
Risk Factors of Acute Kidney Injury After Major Elective Non-Cardiac Surgery : A Prospective Observational Study
The study is planned to be a single-center study and includes patients who underwent major surgery within Istanbul University Istanbul Faculty of Medicine with an invasive arterial line. Our aim to define the incidence of acute renal injury in our setting and to investigate the risk factors listed in detailed description. After obtaining written informed consent from the patients, preoperative risk factors will be notes. Following standard anesthesia monitoring as well as routine anesthesia induction and maintenance, invasive arterial monitoring will be performed due to the major surgery and hemodynamic values will be recorded throughout the surgery. The primary outcome will be acute renal injury based on KDIGO's (Kidney Disease: Improving Global Outcomes) definition of acute renal damage. Postoperative data regarding this outcome as well as additional data listed in detailed description will be collected.
The study is a single-center study that observes patients who undergo major abdominal surgery within Istanbul University Istanbul Faculty of Medicine. Standard anesthesia monitoring (NIBP, SPO2(oxygen saturation by pulse oximetry), ECG) will be applied to the patients taken to the operation room. Routine anesthesia induction and maintenance will be performed by the anesthetist responsible for the patients. After anesthesia induction, invasive arterial monitoring will be performed. Our data collection and recording will be as follows: preoperative, intraoperative, postoperative. In the preoperative section; * Age, gender, height, weight, BMI of the patient * ASA (American Society of Anesthesiologists) classification, additional diseases and functional capacity * Drugs used (ACE-İ, ARB (angiotensin receptor blocker), Statin, B-blocker, NSAID) * Entry creatinine and eGFR (estimated glomerular filtration rate) calculated with CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) * Entry hemoglobin, lymphocyte, CRP (C reactive protein) * The presence of ascites in the abdomen In the intraoperative section; * Surgery (gynecological oncology surgery, gastrointestinal surgery, genitourinary surgery) and its duration * Applied form of anesthesia (general-regional) * Liquids given during the operation (Crystalloid (isotonic, isolyte, lactated ringer), colloid, albumin) and their amounts oNoradrenaline requirement * Use of diuretic, NSAID * Blood transfusion * Total amount of bleeding during the operation * First arterial blood gas electrolytes taken due to routine major surgery * The lowest amount of hemoglobin seen during the operation * Routine invasive artery monitorization due to major surgery, and mean arterial pressure In the postoperative section; * Requirement of intensive care * Blood transfusion requirement * Noradrenaline requirement * Use of diuretic and NSAID * Electrolyte values in the first blood gas taken routinely * Creatinine value immediately after the surgery and at 24th and 48th hours * First 48-hour urine output The diagnosis of acute renal injury is based on KDIGO's definition of acute renal damage. By analyzing from this information, significant risk factors for acute renal damage are identified and measures are taken against them.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Istanbul University Istanbul Faculty of Medicine Departmant of Anesthesiology and Reanimation
Istanbul, Turkey (Türkiye)
Start Date
June 1, 2019
Primary Completion Date
November 1, 2020
Completion Date
February 1, 2021
Last Updated
September 22, 2021
425
ACTUAL participants
Crystalloid Solutions
DRUG
Colloid Blood Volume Expanders
DRUG
blood replacement
OTHER
Diuretic
DRUG
noradrenaline
DRUG
Non-Steroidal Anti-Inflammatory Analgesics
DRUG
Lead Sponsor
Istanbul University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02417896